Soo RA - Search Results

1

Lorlatinib for the treatment of ALK-positive metastatic non-small cell lung cancer.

Choo JR, Soo RA. Choo JR, et al. Among authors: soo ra. Expert Rev Anticancer Ther. 2020 Apr;20(4):233-240. doi: 10.1080/14737140.2020.1744438. Epub 2020 Mar 25. Expert Rev Anticancer Ther. 2020. PMID: 32186215 Review.

2

The role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of advanced stage non-small cell lung cancer.

Voon PJ, Chul Cho B, Yeo WL, Soo RA. Voon PJ, et al. Among authors: soo ra. J Thorac Dis. 2010 Sep;2(3):144-53. doi: 10.3978/j.issn.2072-1439.2010.02.03.6. J Thorac Dis. 2010. PMID: 22263036 Free PMC article.

3

ROS1 as a 'druggable' receptor tyrosine kinase: lessons learned from inhibiting the ALK pathway.

Ou SH, Tan J, Yen Y, Soo RA. Ou SH, et al. Among authors: soo ra. Expert Rev Anticancer Ther. 2012 Apr;12(4):447-56. doi: 10.1586/era.12.17. Expert Rev Anticancer Ther. 2012. PMID: 22500682 Review.

4

Immunotherapy in the treatment of non-small cell lung cancer.

Sundar R, Soong R, Cho BC, Brahmer JR, Soo RA. Sundar R, et al. Among authors: soo ra. Lung Cancer. 2014 Aug;85(2):101-9. doi: 10.1016/j.lungcan.2014.05.005. Epub 2014 May 14. Lung Cancer. 2014. PMID: 24880938 Free PMC article. Review.

5

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, Iyer S, Reisman A, Wilner KD, Tursi J, Blackhall F; PROFILE 1014 Investigators. Solomon BJ, et al. N Engl J Med. 2014 Dec 4;371(23):2167-77. doi: 10.1056/NEJMoa1408440. N Engl J Med. 2014. PMID: 25470694 Free article. Clinical Trial.

6

Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC).

Kumarakulasinghe NB, van Zanwijk N, Soo RA. Kumarakulasinghe NB, et al. Among authors: soo ra. Respirology. 2015 Apr;20(3):370-8. doi: 10.1111/resp.12490. Epub 2015 Feb 17. Respirology. 2015. PMID: 25689095 Free article. Review.

7

Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer.

Tan CS, Cho BC, Soo RA. Tan CS, et al. Among authors: soo ra. Lung Cancer. 2016 Mar;93:59-68. doi: 10.1016/j.lungcan.2016.01.003. Epub 2016 Jan 8. Lung Cancer. 2016. PMID: 26898616 Review.

8

Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer.

Ang YL, Lim JS, Soo RA. Ang YL, et al. Among authors: soo ra. Onco Targets Ther. 2016 May 30;9:3187-95. doi: 10.2147/OTT.S84356. eCollection 2016. Onco Targets Ther. 2016. PMID: 27313464 Free PMC article. Review.

9

Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.

Soo RA, Kubo A, Ando M, Kawaguchi T, Ahn MJ, Ou SI. Soo RA, et al. Clin Lung Cancer. 2017 Sep;18(5):535-542. doi: 10.1016/j.cllc.2017.01.005. Epub 2017 Jan 19. Clin Lung Cancer. 2017. PMID: 28433570

10

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.

Peters S, Camidge DR, Shaw AT, Gadgeel S, Ahn JS, Kim DW, Ou SI, Pérol M, Dziadziuszko R, Rosell R, Zeaiter A, Mitry E, Golding S, Balas B, Noe J, Morcos PN, Mok T; ALEX Trial Investigators. Peters S, et al. N Engl J Med. 2017 Aug 31;377(9):829-838. doi: 10.1056/NEJMoa1704795. Epub 2017 Jun 6. N Engl J Med. 2017. PMID: 28586279 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters